Mckesson Propafenone Tablets Recall: Moisture Content Issue
Mckesson Packaging Services recalls 150mg Propafenone Hydrochloride tablets with moisture content out of specification. Rx-only medication may pose safety risks due to improper moisture levels.
Lower-risk recall
Failed moisture limits: Out of specification for moisture content.
Contact the company
What happened, in plain English
Mckesson Packaging Services is recalling 150mg Propafenone Hydrochloride tablets that failed moisture content tests. This could affect medication stability and safety for patients using these prescription heart medications. Read more at govinfonow.com/recall/41296-mckesson-propafenone-tablets-recall-moisture-content-issue.
Source Summary by GovInfoNow · govinfonow.com/recall/41296-mckesson-propafenone-tablets-recall-moisture-content-issue · Updated October 7, 2026 · FDA enforcement record: FDA #D-1128-2017
Cite this page
“Mckesson Propafenone Tablets Recall: Moisture Content Issue.” GovInfoNow, updated October 7, 2026. https://govinfonow.com/recall/41296-mckesson-propafenone-tablets-recall-moisture-content-issue. Based on FDA recall #D-1128-2017 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1128-2017%22&limit=1).
Why it’s dangerous
The tablets failed moisture content tests, which could lead to instability in the medication. This might affect the drug's effectiveness or safety when taken as prescribed.
Who’s affected
Prescription heart medication users who received these specific tablets from the recalled lots. Patients with heart conditions requiring Propafenone Hydrochloride are most at risk.
How to tell if you have this one
Check for the 150mg Propafenone Hydrochloride tablets in 100-count boxes with NDC 63739-509-10. Look for lot numbers 0112313 (exp. 12/2017), 0113376 (exp. 06/2018), or 0113645 (exp. 02/2019).
- Brand
Mckesson Packaging Services- Category
Drug
What to do — step by step
Check Medication Details
Verify the product's lot number and expiration date against the recalled numbers listed in the notice.
Where it went and when
Where it was distributed
Distributed in 5 states.
FDA distribution: “PA, OH, IL, CO, LA” States read from FDA’s own wording; “not listed” means the notice does not name it.
States: Colorado, Illinois, Louisiana, Ohio, Pennsylvania.
Recall timeline
FDA terminated this recall 2.7 years after the firm started it.
- Firm started the recall
- FDA classified it Class III
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-1128-2017 (August 28, 2017) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1128-2017 to see it in context.
- Plain-language summary written by qwen3:4b on October 7, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.